UPB1: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
m (Bot: HTTP→HTTPS) |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | '''Beta-ureidopropionase''' is an [[enzyme]] that in humans is encoded by the ''UPB1'' [[gene]].<ref name="pmid10542323">{{cite journal |vauthors=Vreken P, van Kuilenburg AB, Hamajima N, Meinsma R, van Lenthe H, Gohlich-Ratmann G, Assmann BE, Wevers RA, van Gennip AH | title = cDNA cloning, genomic structure and chromosomal localization of the human BUP-1 gene encoding beta-ureidopropionase | journal = Biochim Biophys Acta | volume = 1447 | issue = 2–3 | pages = 251–7 |date=Dec 1999 | pmid = 10542323 | pmc = | doi = 10.1016/s0167-4781(99)00182-7}}</ref><ref name="entrez">{{cite web | title = Entrez Gene: UPB1 ureidopropionase, beta| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=51733| accessdate = }}</ref> | ||
}} | |||
{{ | |||
| | |||
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | <!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | ||
{{PBB_Summary | {{PBB_Summary | ||
| section_title = | | section_title = | ||
| summary_text = This gene encodes a protein that belongs to the CN hydrolase family. Beta-ureidopropionase catalyzes the last step in the pyrimidine degradation pathway. The pyrimidine bases uracil and thymine are degraded via the consecutive action of dihydropyrimidine dehydrogenase (DHPDH), dihydropyrimidinase (DHP) and beta-ureidopropionase (UP) to beta-alanine and beta-aminoisobutyric acid, respectively. UP deficiencies are associated with N-carbamyl-beta-amino aciduria and may lead to abnormalities in neurological activity.<ref name="entrez" | | summary_text = This gene encodes a protein that belongs to the CN hydrolase family. Beta-ureidopropionase catalyzes the last step in the pyrimidine degradation pathway. The pyrimidine bases [[uracil]] and [[thymine]] are degraded via the consecutive action of [[dihydropyrimidine dehydrogenase]] (DHPDH), [[dihydropyrimidinase]] (DHP) and [[beta-ureidopropionase]] (UP) to [[beta-alanine]] and [[beta-aminoisobutyric acid]], respectively. UP deficiencies are associated with N-carbamyl-beta-amino aciduria and may lead to abnormalities in neurological activity.<ref name="entrez" /> | ||
}} | }} | ||
== Interactive pathway map == | |||
{{FluoropyrimidineActivity WP1601|highlight=UPB1}} | |||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
{{PBB_Further_reading | {{PBB_Further_reading | ||
| citations = | | citations = | ||
*{{cite journal | author=Thomas HR | *{{cite journal | author=Thomas HR |title=Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism |journal=Pharmacogenet. Genomics |volume=18 |issue= 1 |pages= 25–35 |year= 2008 |pmid= 18216719 |doi= 10.1097/FPC.0b013e3282f2f134 |name-list-format=vanc| author2=Ezzeldin HH | author3=Guarcello V | display-authors=3 | last4=Mattison | first4=Lori K. | last5=Fridley | first5=Brooke L. | last6=Diasio | first6=Robert B. }} | ||
*{{cite journal | author=Thomas HR | *{{cite journal | author=Thomas HR |title=Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism |journal=Pharmacogenet. Genomics |volume=17 |issue= 11 |pages= 973–87 |year= 2008 |pmid= 18075467 |doi= 10.1097/FPC.0b013e3282f01788 |name-list-format=vanc| author2=Ezzeldin HH | author3=Guarcello V | display-authors=3 | last4=Mattison | first4=Lori K. | last5=Fridley | first5=Brooke L. | last6=Diasio | first6=Robert B. }} | ||
*{{cite journal | author=van Kuilenburg AB | *{{cite journal | author=van Kuilenburg AB |title=Genetic analysis of the first 4 patients with beta-ureidopropionase deficiency |journal=Nucleosides Nucleotides Nucleic Acids |volume=25 |issue= 9–11 |pages= 1093–8 |year= 2007 |pmid= 17065070 |doi= 10.1080/15257770600956870 |name-list-format=vanc| author2=Meinsma R | author3=Assman B | display-authors=3 | last4=Hoffman | first4=G. | last5=Voit | first5=T. | last6=Ribes | first6=A. | last7=Lorente | first7=I. | last8=Busch | first8=R. | last9=Mayatepek | first9=E. }} | ||
*{{cite journal | author=Collins JE | *{{cite journal | author=Collins JE |title=A genome annotation-driven approach to cloning the human ORFeome |journal=Genome Biol. |volume=5 |issue= 10 |pages= R84 |year= 2005 |pmid= 15461802 |doi= 10.1186/gb-2004-5-10-r84 | pmc=545604 |name-list-format=vanc| author2=Wright CL | author3=Edwards CA | display-authors=3 | last4=Davis | first4=Matthew P | last5=Grinham | first5=James A | last6=Cole | first6=Charlotte G | last7=Goward | first7=Melanie E | last8=Aguado | first8=Begoña | last9=Mallya | first9=Meera }} | ||
*{{cite journal | author=van Kuilenburg AB | *{{cite journal | author=van Kuilenburg AB |title=beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities |journal=Hum. Mol. Genet. |volume=13 |issue= 22 |pages= 2793–801 |year= 2006 |pmid= 15385443 |doi= 10.1093/hmg/ddh303 |name-list-format=vanc| author2=Meinsma R | author3=Beke E | display-authors=3 | last4=Assmann | first4=B | last5=Ribes | first5=A | last6=Lorente | first6=I | last7=Busch | first7=R | last8=Mayatepek | first8=E | last9=Abeling | first9=NG }} | ||
*{{cite journal | author=Ota T | *{{cite journal | author=Ota T |title=Complete sequencing and characterization of 21,243 full-length human cDNAs |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 |name-list-format=vanc| author2=Suzuki Y | author3=Nishikawa T | display-authors=3 | last4=Otsuki | first4=Tetsuji | last5=Sugiyama | first5=Tomoyasu | last6=Irie | first6=Ryotaro | last7=Wakamatsu | first7=Ai | last8=Hayashi | first8=Koji | last9=Sato | first9=Hiroyuki }} | ||
*{{cite journal | author=Strausberg RL | *{{cite journal | author=Strausberg RL |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |name-list-format=vanc| author2=Feingold EA | author3=Grouse LH | display-authors=3 | last4=Derge | first4=JG | last5=Klausner | first5=RD | last6=Collins | first6=FS | last7=Wagner | first7=L | last8=Shenmen | first8=CM | last9=Schuler | first9=GD }} | ||
*{{cite journal | author=Sakamoto T | *{{cite journal | author=Sakamoto T |title=Expression and properties of human liver beta-ureidopropionase |journal=J. Nutr. Sci. Vitaminol. |volume=47 |issue= 2 |pages= 132–8 |year= 2002 |pmid= 11508704 |doi= 10.3177/jnsv.47.132|name-list-format=vanc| author2=Sakata SF | author3=Matsuda K | display-authors=3 | last4=Horikawa | first4=Y | last5=Tamaki | first5=N }} | ||
*{{cite journal |vauthors=Naguib FN, el Kouni MH, Cha S |title=Enzymes of uracil catabolism in normal and neoplastic human tissues |journal=Cancer Res. |volume=45 |issue= 11 Pt 1 |pages= 5405–12 |year= 1985 |pmid= 3931905 |doi= }} | |||
*{{cite journal | | |||
}} | }} | ||
{{refend}} | {{refend}} | ||
{{Nucleotide metabolism enzymes}} | |||
{{ | <!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | ||
{{PBB_Controls | |||
{{ | | update_page = yes | ||
| require_manual_inspection = no | |||
| update_protein_box = yes | |||
| update_summary = yes | |||
| update_citations = yes | |||
}} | |||
{{gene-22-stub}} |
Latest revision as of 09:50, 17 September 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Beta-ureidopropionase is an enzyme that in humans is encoded by the UPB1 gene.[1][2]
This gene encodes a protein that belongs to the CN hydrolase family. Beta-ureidopropionase catalyzes the last step in the pyrimidine degradation pathway. The pyrimidine bases uracil and thymine are degraded via the consecutive action of dihydropyrimidine dehydrogenase (DHPDH), dihydropyrimidinase (DHP) and beta-ureidopropionase (UP) to beta-alanine and beta-aminoisobutyric acid, respectively. UP deficiencies are associated with N-carbamyl-beta-amino aciduria and may lead to abnormalities in neurological activity.[2]
Interactive pathway map
Click on genes, proteins and metabolites below to link to respective articles.[§ 1]
- ↑ The interactive pathway map can be edited at WikiPathways: "FluoropyrimidineActivity_WP1601".
References
- ↑ Vreken P, van Kuilenburg AB, Hamajima N, Meinsma R, van Lenthe H, Gohlich-Ratmann G, Assmann BE, Wevers RA, van Gennip AH (Dec 1999). "cDNA cloning, genomic structure and chromosomal localization of the human BUP-1 gene encoding beta-ureidopropionase". Biochim Biophys Acta. 1447 (2–3): 251–7. doi:10.1016/s0167-4781(99)00182-7. PMID 10542323.
- ↑ 2.0 2.1 "Entrez Gene: UPB1 ureidopropionase, beta".
Further reading
- Thomas HR, Ezzeldin HH, Guarcello V, et al. (2008). "Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism". Pharmacogenet. Genomics. 18 (1): 25–35. doi:10.1097/FPC.0b013e3282f2f134. PMID 18216719.
- Thomas HR, Ezzeldin HH, Guarcello V, et al. (2008). "Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism". Pharmacogenet. Genomics. 17 (11): 973–87. doi:10.1097/FPC.0b013e3282f01788. PMID 18075467.
- van Kuilenburg AB, Meinsma R, Assman B, et al. (2007). "Genetic analysis of the first 4 patients with beta-ureidopropionase deficiency". Nucleosides Nucleotides Nucleic Acids. 25 (9–11): 1093–8. doi:10.1080/15257770600956870. PMID 17065070.
- Collins JE, Wright CL, Edwards CA, et al. (2005). "A genome annotation-driven approach to cloning the human ORFeome". Genome Biol. 5 (10): R84. doi:10.1186/gb-2004-5-10-r84. PMC 545604. PMID 15461802.
- van Kuilenburg AB, Meinsma R, Beke E, et al. (2006). "beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities". Hum. Mol. Genet. 13 (22): 2793–801. doi:10.1093/hmg/ddh303. PMID 15385443.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Sakamoto T, Sakata SF, Matsuda K, et al. (2002). "Expression and properties of human liver beta-ureidopropionase". J. Nutr. Sci. Vitaminol. 47 (2): 132–8. doi:10.3177/jnsv.47.132. PMID 11508704.
- Naguib FN, el Kouni MH, Cha S (1985). "Enzymes of uracil catabolism in normal and neoplastic human tissues". Cancer Res. 45 (11 Pt 1): 5405–12. PMID 3931905.
This article on a gene on human chromosome 22 is a stub. You can help Wikipedia by expanding it. |